Form 4: EXAS Exec's RSU Vesting & Tax Withholding
Insider Transaction Report
Exact Sciences EVP Brian Baranick reported the vesting of restricted stock units and subsequent share disposition for tax purposes.
Summary
- Brian Baranick, EVP, GM, Precision Oncology at Exact Sciences Corp (EXAS), reported transactions on August 5, 2025.
- Acquired 5,350 shares of common stock due to the vesting of a restricted stock unit (RSU) award.
- Disposed of 2,717 shares of common stock at $46.83 per share to cover tax withholding obligations related to the RSU vesting.
- Following these transactions, Baranick directly holds 25,226 shares of common stock and indirectly holds 670 shares in a 401(k) Plan.
- Baranick also holds an additional 73,080 vested and unvested options and restricted stock units.
- The RSU award, granted on August 5, 2024, partially vested on August 5, 2025, and vests in four equal annual installments.
Sentiment
Score: 5
Explanation: The filing reports routine executive compensation transactions (RSU vesting and tax-related share disposition), which are neutral in sentiment and do not indicate significant positive or negative developments for the company.
Positives
- Vesting of 5,350 restricted stock units indicates a portion of executive compensation becoming realized.
Negatives
- Disposition of 2,717 shares for tax withholding purposes reduces direct share ownership.
Future Outlook
No forward-looking statements or guidance are provided.
Industry Context
This is a routine insider transaction filing and does not provide specific industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Brian Baranick granted Power of Attorney to several individuals (Mark Busch, James Herriott, Henry Weiner, Ashley Hein, Aaron Dixon) to handle his SEC filings (Forms 3, 4, 5, 13D, 13G, 144) and EDGAR system management. | 05/14/2025 | Streamlines the process for executive compliance with SEC reporting requirements, ensuring timely and accurate filings. |
Stakeholder Impact
- Shareholders: Provides transparency on executive compensation and insider holdings, which is generally positive for corporate governance.
Next Steps
- Future annual vesting installments of the RSU award granted on August 5, 2024.
Key Dates
| Date | Description |
|---|---|
| 08/05/2024 | Date of restricted stock unit award grant. |
| 05/14/2025 | Date Power of Attorney was executed by Brian Baranick. |
| 08/05/2025 | Date of RSU vesting and related share transactions. |
| 08/07/2025 | Date Form 4 was signed by attorney-in-fact. |
Recommendation
holdThis Form 4 filing details a routine executive compensation event involving the vesting of restricted stock units and the subsequent sale of shares to cover tax obligations. Such transactions are standard and do not typically indicate a change in the company's fundamental performance or outlook. Therefore, it does not provide new information that would warrant a change from a 'hold' recommendation.
Keywords
Exact Sciences, EXAS, Brian Baranick, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Executive Compensation, Biotechnology, Oncology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.